$UNCY (Unicycive Therapeutics) – PDUFA Date June 29: High-Probability Catalyst + Short Squeeze Setup
Unicycive Therapeutics ($UNCY - $7.87 - Mark cap: 210M) is a late-stage biotech focused on kidney disease treatments. Its lead product, **Oxylanthanum Carbonate (OLC)**, is a next-generation phosphate binder for chronic kidney disease (CKD) patients on dialysis. OLC is designed …